LEMAITRE VASCULAR INC (LMAT)
Health Care · Vascular surgery medical devices · NASDAQ
LeMaitre Vascular develops specialized medical devices and tissue-based solutions for vascular and cardiovascular surgery, targeting an aging population with peripheral vascular disease.
What LEMAITRE VASCULAR INC does
LeMaitre Vascular designs, manufactures, and markets medical devices and tissue-based vascular grafts and patches for vascular and cardiovascular surgery. The company offers both synthetic and biologic solutions for vascular reconstruction, targeting vascular surgeons and other interventional specialists. LeMaitre operates internationally across multiple surgical markets, with a focus on innovative products that address peripheral vascular disease, aneurysm repair, and related vascular conditions. The company maintains its own manufacturing facilities and sources human tissue for its biologic product lines.
Themes: ["Vascular surgery / peripheral vascular disease","Cardiovascular surgical devices","Biologic tissue-based products","Medical device manufacturing","Aging population / geriatric surgery"]
Fundamentals
- Price$102.40 as of 2026-07-09 close
- Market cap$2.3B as of 2026-07-10
- 1-year return+21.1% as of 2026-07-09 close
- P/E36.68 as of 2026-07-10
- Net margin+24.4% as of 2026-07-10
- Gross margin+72.4% as of 2026-07-10
- ROE+16.2% as of 2026-07-10
- Debt / equity0.42 as of 2026-07-10
- Revenue growth (YoY)+13.3% as of 2026-07-10
- Revenue CAGR (3y)+15.6% SEC XBRL
- Beta0.54 as of 2026-07-10
Dividend: yield +1.0%; 5-year non-decreasing per-share dividend streak (SEC XBRL).
Key risks (from latest filing)
["Dependence on vascular surgeons and limited sales call points; difficulty engaging broader surgical specialties may constrain market reach","Reliance on sole- or limited-source suppliers and human tissue procurement; supply disruptions, manufacturing facility damage, or regulatory compliance failures could halt production","Competition from established major medical device companies and alternative medical technologies; pricing pressure and inability to maintain historic profit growth margins"]
Competitors & peers
- W. L. Gore & Associates (vascular grafts and patches)
- Medtronic (cardiovascular and vascular devices)
- Abbott Laboratories (vascular devices)
- Boston Scientific (interventional vascular devices)
- Cook Medical (vascular grafts and devices)
- Getinge (vascular surgery products)
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.